Revenue Breakdown
Composition ()
No data
Revenue Streams
Resmed Inc (RMD) generates its revenue through a diversified portfolio of business segments. Currently, the largest contributor to its top-line growth is Devices, accounting for 50.9% of total sales, equivalent to $680.31M. Another important revenue stream is Masks and other. Understanding this composition is critical for investors evaluating how RMD navigates market cycles within the Advanced Medical Equipment & Technology industry.
Profitability & Margins
Evaluating the bottom line, Resmed Inc maintains a gross margin of 60.93%. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at 34.97%, while the net margin is 27.59%. These profitability ratios, combined with a Return on Equity (ROE) of 25.68%, provide a clear picture of how effectively RMD converts its operational activities into shareholder value.
Comparative Benchmarking
In the context of the broader market, RMD competes directly with industry leaders such as A and GEHC. With a market capitalization of $39.57B, it holds a leading position in the sector. When comparing efficiency, RMD's gross margin of 60.93% stands against A's 53.14% and GEHC's 39.68%. Such benchmarking helps identify whether Resmed Inc is trading at a premium or discount relative to its financial performance.
